<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4510</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2022.14813</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Effect of Percutaneous Transvenous Mitral Commissurotomy in Severe Mitral Stenosis: A Cross-Sectional Study&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rafique</surname><given-names>Muhammad</given-names></name></contrib><contrib contrib-type="author"><name><surname>Salam</surname><given-names>Abdul</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rehman</surname><given-names>Fazal ur</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Wajid</given-names></name></contrib><contrib contrib-type="author"><name><surname>Azim</surname><given-names>Waqar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hashim</surname><given-names>Muhammad</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>19</day><month>04</month><year>2022</year></pub-date><volume>)</volume><issue/><fpage>73</fpage><lpage>75</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: The inflow obstruction from the left atrium to the left ventricle due to rheumatic involvement of apparatus is the main cause of Mitral stenosis. The patients with mitral valve involvement are found to have a combination of stenosis and regurgitation. Due to the thromboembolic phenomenon, left atrial dilatation and stasis predispose thrombus formation. So, even after percutaneous treatment, the elevated pressure in MS patients causes morbidity and mortality. Aim: To assess the effect of percutaneous transvenous mitral commissurotomy (PTMC) in reducing pulmonary hypertension in patients with severe mitral stenosis Methodology: A total of 134 patients were included in the study. All of them had severe mitral stenosis with elevated pressure of more than 55 mmHg. The age range of patients was between 16 to 62 years. These patients were assessed by echocardiography post-PTMC. Age, gender, and other demographic details were also noted. Results: Mean age of patients was 36.44__ampersandsignplusmn;11.37 years. Hypertension was found in 49 patients, and diabetes in 48 patients. Mean baseline systolic pressure was found to be 73.62+9.10 mmHg and mean artery systolic pressure was 44.09__ampersandsignplusmn;5.06 mmHg. After the commissurotomy, the pulmonary artery systolic pressure reduced from baseline by 38.90+5.20. In 125 patients the Transvenous mitral commissurotomy was effective and in 9 patients it was ineffective. Conclusion: This study was found to be successful because it had fewer patients with pulmonary hypertension after the completion of treatment. For the reduction in mean pulmonary artery, systolic pressure balloon valvotomy is a useful technique irrespective of age and gender.&#13;
</p></abstract><kwd-group><kwd>Pulmonary artery systolic pressure</kwd><kwd> Balloon valvotomy</kwd><kwd> Effectiveness</kwd><kwd> Transvenous mitral commissurotomy</kwd><kwd> Pulmonary  hypertension</kwd><kwd> Thromboembolic Phenomenon</kwd></kwd-group></article-meta></front></article>
